December 11, 2012
British Columbia Securities Commission
701 West Georgia Street
P.O. Box 10142, Pacific Centre
Vancouver, B.C. V7Y 1L2
To Whom it may Concern:
The Ontario Securities Commission has informed me on December 1, 2012 to contact the British Columbia Securities Commission as it is the Principal Regulator of AKELA PHARMA INC.
Akela Pharma Inc. management has neglected:
1
To duly inform its shareholders via its website WWW.AKELAPHARMA.COM of its headquarters moving from the State of Texas to the State of California in October 2012 and at what address/telephone number(s) the said new headquarters are located in the State of California.
2
To duly inform its shareholders via its website WWW.AKELAPHARMA.COM of its shares delisting from the Toronto Stock Exchange in November 2012 and the outcome of the company shares.
3
To duly inform its shareholders via its website WWW.AKELAPHARMA.COM in November 2012 of what lies ahead for the company, subsequent to its shares delisting?
You will understand that as a company minority shareholder, alike others, I dont appreciate at all the disgraceful behaviour of BREACH OF TRUST undertakenby management of Akela Pharma Inc. in this messy case.
I want to know officially from the British Columbia Securities Commission what recourses are available to bring Akela Pharma Inc.'s management to accountability.
Thank you.